CHRISTUS SPOHN ALICE — History
CCN 450828 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$65M
Latest Revenue (FY2022)
+7.8%
Revenue CAGR (3yr)
13.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $56M | $62M | $65M | +4.5% | +7.8% |
| Operating Expenses | $51M | $53M | $56M | +5.8% | +5.2% |
| Operating Margin | 9.3% | 14.7% | 13.6% | -7.5% | +21.0% |
| Net Income | $5M | $9M | $9M | -3.4% | +30.5% |
| Licensed Beds | 72 | 72 | 72 | +0.0% | +0.0% |
| Total Patient Days | 8,246 | 8,429 | 6,798 | -19.3% | -9.2% |
| Medicare Day % | 28% | 25% | 21% | -16.2% | -13.0% |
| Medicaid Day % | 2% | 1% | 1% | -11.7% | -10.2% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.2% ($56M → $65M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.8%
This Hospital
+7.6%
State Avg
Latest Margin
13.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $70M | 15.8% |
| FY2024 (proj) | $74M | 18.0% |
| FY2025 (proj) | $79M | 20.1% |